"TBSF" (20%) Human Albumin Solution

Active ingredient:

Albumin, Quantity: 200 g/L

Available from:

CSL Behring Australia Pty Ltd

INN (International Name):

Albumin

Pharmaceutical form:

Injection, solution

Composition:

Excipient Ingredients: octanoate; sodium

Administration route:

Intravenous

Units in package:

50mL, 100mL

Class:

Medicine Listed (Export Only)

Prescription type:

(S1) This Schedule is intentionally blank

Therapeutic indications:

Hypoproteinaemia in the acutely ill patient TBSF (20%) Human Albumin Solution is administered when there are existing or anticipated clinical problems or complications from reduced oncotic pressure, and/or as an adjunct to diuretic therapy. Shock. TBSF (20%) Human Albumin Solution may be used for the resuscitation of patients in shock due to acute loss of blood or plasma, but 4 - 5% human albumin is preferred when available. Burns. Extensive burns are followed by sequential shifts in the distribution of body water, salt and proteins resulting in hypovolaemic shock and circulatory failure.

Product summary:

Visual Identification: Clear, slightly viscous almost colourless, yellow or green; Container Type: Vial; Container Life Time: 4 Years; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Listed (Export Only)

Authorization date:

2006-03-01